Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Open-label Single Arm Study of Sunitinib in Patients With Advanced Cholangiocarcinoma

NCT01718327 is registered in ClinicalTrials.gov with GERCOR - Multidisciplinary Oncology Cooperative Group as lead sponsor.

NCT NCT01718327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01718327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Open-label Single Arm Study of Sunitinib in Patients With Advanced Cholangiocarcinoma
Lead sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase
Phase 2
Overall status
Completed
Start date
September 1, 2011
Completion date
November 17, 2016
Enrollment
53 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable and advanced cholangiocarcinoma